The Science Hat Podcast - Season 3 Episode 2 - Stock market dynamics: Not an exact science

Global biotechnology has experienced a tumultuous ride in financial markets over the last three years since Clarity listed on the Australian Securities Exchange (ASX). Driven by its robust pipeline, clinical data and with strong Australian science at its core, Clarity continues to reach new financial milestones, including being added to several indexes this year such as the ASX300, MSCI and, most recently, the ASX200. Watch season 3 episode 2, featuring Clarity’s Executive Chairperson, Dr Alan Taylor, who has substantial life sciences experience in capital markets with over a decade spent in investment banking, and Healthcare Analyst, Melissa Benson, as they discuss the fascinating world of share trading and market dynamics, as well as Clarity’s continued focus of building long-term value for shareholders through an unwavering dedication to better treating children and adults with cancer. Click on the following link to watch previous episodes of the Science Hat podcast and learn more about Clarity’s TCT platforms: https://www.claritypharmaceuticals.com